Glapp

Glapp is a GLP-1 tracker app for people using Ozempic, Wegovy, Mounjaro, or Zepbound. It is designed to help users understand their weekly injection routine, track how their body responds over time, and turn each shot into a clearer plan rather than a guess.

The app includes shot-phase tracking so users can see whether they are in a rise, peak, or fade phase and use that to anticipate hunger, cravings, and side effects. It also shows estimated medication levels for semaglutide and tirzepatide across the weekly cycle. Other features include logging injections, custom doses, and exact shot times; tracking vials, remaining doses, and expiration dates; and progress reports that surface patterns and trends without manual math. Glapp also offers an on-track check that compares results with clinical trials and people on the same medication and dose, plus answers to GLP-1 questions backed by research and real-world experience.

Glapp is presented as a support tool rather than a healthcare provider, and it says it does not tell users what dose to take or replace medical advice. It is available as a free native app for iPhone, iPad, and Android, and it can also be used in a web browser. The account-based sync keeps GLP-1 history with the user across reinstalling, changing phones, or switching between iPhone, Android, and web. The product also states that users choose what to track, can delete their data at any time, and that it does not sell or monetize data. No separate open-source or paid licensing terms are given in the available text.